SNSE
Sensei Biotherapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$14.48M
P/E Ratio
—
EPS
$-142.72
Beta
-0.23
52W High
$36.76
52W Low
$5.86
50-Day MA
$23.81
200-Day MA
$16.23
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, is dedicated to the discovery and development of therapies with an initial focus on cancer treatments. The company is headquartered in Rockville, Maryland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-185.51M |
| Operating Margin | 0.00% |
| Return on Equity | -74.00% |
| Return on Assets | -95.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-102.43 |
| Price-to-Book | 1.26 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.36 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.34M |
| Float | 811,870 |
| % Insiders | 28.29% |
| % Institutions | 153.02% |
Historical Volatility
HV 10-Day
171.24%
HV 20-Day
161.14%
HV 30-Day
137.01%
HV 60-Day
124.94%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($52.50 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026